July 30 (Reuters) - Curis Inc CRIS.O: * Curis doses first five patients in Takeaim CLL study
Back to newsCuris Doses First Five Patients In Takeaim CLL StudyCCRIS•2026-07-30Reuters brief on Curis clinical studyJuly 30 (Reuters) - Curis Inc CRIS.O: Curis doses first five patients in Takeaim CLL study Related NewsNNelnet Bank files FDIC call report for quarter ended June 30, 2026NNI•2026-07-30BBank of Botetourt Q2 profit jumps 67% on one-time gainBORT•2026-07-30RRBC says Canadian defined-benefit pension plans post 6% median return in Q2 2026RY•2026-07-30
CRIS•CRIS•CRIS•CRIS•
